Photo from Cell Stress and Immunity Lab/X
Jul 23, 2024, 00:19
TIM3+VISTA+ macrophage subset that mediates resistance to anticancer, Immunotherapy and chemotherapy -Cell Stress and Immunity Lab
Cell Stress and Immunity Lab posted on X about recent paper by Isaure Vanmeerbeek et al., commenting:
“Thrilled to share our lab’s latest research on unique, evolutionarily conserved, TIM3+VISTA+ macrophage subset that mediates resistance to anticancer, Immunotherapy and chemotherapy!”
Journal: Science Advances
Author: Isaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, Raquel S. Laureano, Jannes Govaerts, Rosa Trotta, Samantha Pretto, Shikang Zhao, Sarah Trusso Cafarello, Joren Verelst, Maarten Jacquemyn, Martyna Pociupany, Louis Boon, Susan M. Schlenner, Sabine Tejpar, Dirk Daelemans, Massimiliano Mazzone, Abhishek D. Garg
Source: Cell Stress and Immunity Lab/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14